ML291
ML291 is a UPR (unfolded protein response) -inducing sulfonamidebenzamide. ML291 overwhelms the adaptive capacity of the UPR and induces apoptosis in a variety of solid cancer models. ML291 can activate the PERK/eIF2a/CHOP (apoptotic) arm of the UPR and reduce leukemic cell burden[1].
Product Specifications
CAS Number
1523437-16-2
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis; Eukaryotic Initiation Factor (eIF) ; PERK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ml291.html
Purity
99.80
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(C1=CC=C([N+]([O-])=O)O1)NC2=CC=C(S(=O)(N3CCC(Cl)CC3)=O)C=C2
Molecular Formula
C16H16ClN3O6S
Molecular Weight
413.83
Precautions
H315, H319, H335
References & Citations
[1]Danielle Garshott, et al. The Novel Sulfonamidebenzamide ML291 Activates Apoptotic UPR Signaling in Pediatric Leukemia. Blood. 2016,128 (22) :3523.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
S100A1 (Melanoma Marker) (S100A1/1942), CF640R conjugate, 0.1mg/mL
